MENU

Fox Chase Cancer Center News

September 24, 2020

Fox Chase Researchers Highlight Role of Lipids in Controlling Pancreatic Cancer Aggressiveness

PHILADELPHIA (September 24, 2020)—In a study published today in the prestigious journal Cancer Cell, researchers at Fox Chase Cancer Center showed how altering lipid metabolism may contribute to sustaining tumor growth in patients with pancreatic ductal adenocarcinoma. The finding could help overcome a major problem in pancreatic cancer treatment resistance and metastatic spread, the researchers said.

September 24, 2020

Fox Chase Researchers Find Ripretinib Significantly Improves Survival for Patients With Advanced Gastrointestinal Tumors

PHILADELPHIA (September 24, 2020)—Researchers at Fox Chase Cancer Center recently published the results of an international study showing improved survival for patients with advanced gastrointestinal stromal tumors who used ripretinib (Qinlock) when compared with patients taking a placebo.

September 22, 2020

Pulsed Low-Dose Pelvic Reirradiation Safe, Provided Tangible Benefit for Patients With Few Other Options

PHILADELPHIA (September 22, 2020) – Patients with cancer who have had prior radiation to the pelvic region often have very few treatment options if the cancer comes back or a new cancer is discovered in the same location. Researchers at Fox Chase Cancer Center have now shown that pulsed low-dose rate radiation for pelvic reirradiation was a safe treatment option that resulted in high rates of pain reduction.

September 17, 2020

Fox Chase Cancer Center Increases Issued Patents for Fiscal Years 2019 and 2020

PHILADELPHIA (September 17, 2020)—Fox Chase Cancer Center is pleased to announce that its scientists and clinicians earned several new patents during fiscal years 2019 and 2020, the latter of which ended June 30, 2020. The number of issued patents increased by 71% compared to fiscal years 2017 and 2018 cumulatively.

September 16, 2020

Fox Chase Cancer Center Hosts 2020 Virtual Paws for the Cause

PHILADELPHIA (September 16, 2020)—This year, due to the COVID-19 pandemic, Fox Chase Cancer Center will hold its 21st annual Paws for the Cause dog walk virtually. The event, hosted by the Fox Chase Board of Associates, has raised more than $500,000 for cancer research at Fox Chase, and although this year’s format will be different, the goal is the same.

September 16, 2020

Fox Chase Researchers Receive Grant to Develop Novel Programming Approach to Modulate T Cell Response Following Stem Cell Transplants

PHILADELPHIA (September 16, 2020)—Researchers at Fox Chase Cancer Center recently received a grant to study the molecular mechanisms regulating allogeneic T cell responses that could potentially prevent deaths following stem cell transplants.

September 15, 2020

Fox Chase Researcher Collaborates on Clinical Practice Statement Addressing Social Needs in Gynecologic Oncology

PHILADELPHIA (September 15, 2020)—A researcher at Fox Chase Cancer Center recently published a paper addressing the practice of including social needs in gynecologic oncology.

September 14, 2020

Fox Chase, Temple Researchers Investigate Perceptions of Clinical Trial Participation Among African American Patients

PHILADELPHIA (September 14, 2020)—Researchers at Fox Chase Cancer Center and Temple University College of Public Health recently published survey results that explore the perceptions and concerns among African American patients regarding participation in cancer clinical trials.

Pages

Connect with Fox Chase